+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024 Competing in the POC Diagnostic Testing Market: Supplier Shares, Segment Forecasts for 300 Tests, Latest Trends, Growth Opportunities

  • PDF Icon

    Report

  • 1230 Pages
  • September 2020
  • Region: Global
  • VPG Market Research
  • ID: 4852827

This new 1,230-page report contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.

The report is available by section, and can be customized to specific information needs and budget.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the 10 major POC market segments, including their dynamics, trends, structure,
size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCU
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers

and by test category:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation&nbs
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both
currently marketed and those in development, including their operating characteristics,
features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product
portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and 's proprietary data files.

Contains 1,230 pages and 343 tables


Companies Mentioned

  • Abbott
  • Accriva
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode Genetics
  • Diagnostica Stago
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio
  • Grifols
  • Helena Laboratories
  • Hologic
  • Horiba
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Leica Biosystems
  • Lonza
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sekisui Diagnostics
  • Sequenom
  • Siemens Healthineers
  • Sienco
  • Sysmex
  • Takara Bio
  • Thermo Fisher
  • Tosoh
  • Wako